These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates. Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional Profiling of the Candida auris Response to Exogenous Farnesol Exposure. Jakab Á; Balla N; Ragyák Á; Nagy F; Kovács F; Sajtos Z; Tóth Z; Borman AM; Pócsi I; Baranyai E; Majoros L; Kovács R mSphere; 2021 Oct; 6(5):e0071021. PubMed ID: 34643421 [TBL] [Abstract][Full Text] [Related]
11. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL mBio; 2017 Dec; 8(6):. PubMed ID: 29208749 [No Abstract] [Full Text] [Related]
12. Screening of the Pandemic Response Box Reveals an Association between Antifungal Effects of MMV1593537 and the Cell Wall of de Oliveira HC; Castelli RF; Reis FCG; Samby K; Nosanchuk JD; Alves LR; Rodrigues ML Microbiol Spectr; 2022 Jun; 10(3):e0060122. PubMed ID: 35471056 [TBL] [Abstract][Full Text] [Related]
13. Disruption of Iron Homeostasis and Mitochondrial Metabolism Are Promising Targets to Inhibit Candida auris. Simm C; Weerasinghe H; Thomas DR; Harrison PF; Newton HJ; Beilharz TH; Traven A Microbiol Spectr; 2022 Apr; 10(2):e0010022. PubMed ID: 35412372 [TBL] [Abstract][Full Text] [Related]
14. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375 [No Abstract] [Full Text] [Related]
15. Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development. Wall G; Chaturvedi AK; Wormley FL; Wiederhold NP; Patterson HP; Patterson TF; Lopez-Ribot JL Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104269 [TBL] [Abstract][Full Text] [Related]
16. In vitro antifungal activity of Cinnamomum zeylanicum bark and leaf essential oils against Candida albicans and Candida auris. Tran HNH; Graham L; Adukwu EC Appl Microbiol Biotechnol; 2020 Oct; 104(20):8911-8924. PubMed ID: 32880694 [TBL] [Abstract][Full Text] [Related]
18. Identification of a Phenylthiazole Small Molecule with Dual Antifungal and Antibiofilm Activity Against Candida albicans and Candida auris. Mohammad H; Eldesouky HE; Hazbun T; Mayhoub AS; Seleem MN Sci Rep; 2019 Dec; 9(1):18941. PubMed ID: 31831822 [TBL] [Abstract][Full Text] [Related]
19. Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen DeJarnette C; Luna-Tapia A; Estredge LR; Palmer GE mSphere; 2020 Jun; 5(3):. PubMed ID: 32581079 [TBL] [Abstract][Full Text] [Related]
20. Identification of four compounds from the Pharmakon library with antifungal activity against Candida auris and species of Cryptococcus. de Oliveira HC; Castelli RF; Alves LR; Nosanchuk JD; Salama EA; Seleem M; Rodrigues ML Med Mycol; 2022 Jun; 60(6):. PubMed ID: 35575621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]